Invention Grant
- Patent Title: Pyridone and aza-pyridone compounds and methods of use
-
Application No.: US15281923Application Date: 2016-09-30
-
Publication No.: US10053469B2Publication Date: 2018-08-21
- Inventor: Antonio J. M. Barbosa , Peter A. Blomgren , Kevin S. Currie , Ravi Krishnamoorthy , Jeffrey E. Kropf , Seung H. Lee , Scott A. Mitchell , Daniel Ortwine , Aaron C. Schmitt , Xiaojing Wang , Jianjun Xu , Wendy Young , Honglu Zhang , Zhongdong Zhao , Pavel E. Zhichkin
- Applicant: GILEAD CONNECTICUT, INC. , GENENTECH INC.
- Applicant Address: US CA Foster City US CA South San Franciso
- Assignee: GILEAD CONNECTICUT, INC.,GENENTECH INC.
- Current Assignee: GILEAD CONNECTICUT, INC.,GENENTECH INC.
- Current Assignee Address: US CA Foster City US CA South San Franciso
- Agency: Millen, White, Zelano & Branigan, PC
- Main IPC: C07D519/00
- IPC: C07D519/00 ; C07D487/04 ; C07D495/04 ; C07D498/04 ; A61K31/497 ; A61K31/4985 ; A61K31/501 ; A61K31/5025 ; A61K31/506 ; A61K31/5377 ; A61K31/5383 ; A61K31/5386 ; A61K31/551 ; A61K45/06 ; C07D471/14 ; C07C69/65 ; C07D209/52 ; C07F5/04

Abstract:
Pyridone and aza-pyridone compounds of Formula I are provided, including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
Public/Granted literature
- US20170073356A1 PYRIDONE AND AZA-PYRIDONE COMPOUNDS AND METHODS OF USE Public/Granted day:2017-03-16
Information query